Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Pines

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|July 13, 2002
The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin miceMiri Blank, Yair Levy, Howard Amital, et al.
Autoimmunity|December 17, 2002
Effect of halofuginone on the development of tight skin (TSK) syndromeTracy McGaha, Takao Kodera, Robert Phelps, et al.
Digestive Diseases and Sciences|July 3, 2008
Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptorRafael Bruck, Sigal Weiss, Hussein Aeed, et al.
The Annals of Otology, Rhinology, and Laryngology|June 3, 2006
Halofuginone prevents subglottic stenosis in a canine modelRon Eliashar, Meir Ochana, Bella Maly, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 12, 2008
Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginoneKyla D Huebner, Davinder S Jassal, Orna Halevy, et al.
World Journal of Gastroenterology|October 13, 2006
Hydrodynamics based transfection in normal and fibrotic ratsRita Yeikilis, Shunit Gal, Natalia Kopeiko, et al.
Journal of Hepatology|August 15, 2002
Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic ratsGadi Spira, Nidal Mawasi, Melia Paizi, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?Olga Genin, Gideon Rechavi, Arnon Nagler, et al.
The American Journal of Pathology|January 14, 2017
Elevated Expression of Moesin in Muscular DystrophiesMark Pines, Oshrat Levi, Olga Genin, et al.
Human Molecular Genetics|May 18, 2018
A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null miceHila Barzilai-Tutsch, Melissa Dewulf, Christophe Lamaze, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|July 13, 2002
The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin miceMiri Blank, Yair Levy, Howard Amital, et al.
Autoimmunity|December 17, 2002
Effect of halofuginone on the development of tight skin (TSK) syndromeTracy McGaha, Takao Kodera, Robert Phelps, et al.
Digestive Diseases and Sciences|July 3, 2008
Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptorRafael Bruck, Sigal Weiss, Hussein Aeed, et al.
The Annals of Otology, Rhinology, and Laryngology|June 3, 2006
Halofuginone prevents subglottic stenosis in a canine modelRon Eliashar, Meir Ochana, Bella Maly, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 12, 2008
Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginoneKyla D Huebner, Davinder S Jassal, Orna Halevy, et al.
World Journal of Gastroenterology|October 13, 2006
Hydrodynamics based transfection in normal and fibrotic ratsRita Yeikilis, Shunit Gal, Natalia Kopeiko, et al.
Journal of Hepatology|August 15, 2002
Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic ratsGadi Spira, Nidal Mawasi, Melia Paizi, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?Olga Genin, Gideon Rechavi, Arnon Nagler, et al.
The American Journal of Pathology|January 14, 2017
Elevated Expression of Moesin in Muscular DystrophiesMark Pines, Oshrat Levi, Olga Genin, et al.
Human Molecular Genetics|May 18, 2018
A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null miceHila Barzilai-Tutsch, Melissa Dewulf, Christophe Lamaze, et al.
Pageof 6